Showing results (311-320 of 617) with videos related to
Sort By:
Pageof 62
Cancer|October 1, 1986
Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic diseaseA N Gordon, J J Kavanagh, D M Gershenson, et al.Gynecologic Oncology|July 1, 1988
Recurrent cervical carcinoma after radical hysterectomyD M Larson, L J Copeland, C A Stringer, et al.Obstetrics and Gynecology|November 1, 1987
Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamideD M Gershenson, L J Copeland, J J Kavanagh, et al.Cancer|April 1, 1987
High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterusD M Gershenson, J J Kavanagh, L J Copeland, et al.Biophysical Journal|May 10, 2018
All-Atom Simulations Reveal How Single-Point Mutations Promote Serpin MisfoldingFang Wang, Simone Orioli, Alan Ianeselli, et al.RMD Open|June 7, 2019
Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registryPhilip J Mease, Chitra Karki, Mei Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Reliability and validity of the functional assessment of cancer therapy-ovarianK Basen-Engquist, D Bodurka-Bevers, M A Fitzgerald, et al.Gynecologic Oncology|December 1, 1990
Endometrioid carcinoma of the ovary: retrospective review of 145 casesR C Kline, J T Wharton, E N Atkinson, et al.Cancer|March 26, 1999
The current status of surgical staging of ovarian serous borderline tumorsP S Lin, D M Gershenson, M W Bevers, et al.Journal of Neuro-Oncology|March 16, 2004
Brain metastases in patients with ovarian carcinoma: prognostic factors and outcomeZvi R Cohen, Dima Suki, Jeffrey S Weinberg, et al.Pageof 62